Tianjin Ringpu Bio-technology Co., Ltd.

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100000TV1
CNY
19.27
-0.1 (-0.52%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
Net Sales
3,043.59
2,686.40
2,063.85
1,988.16
1,981.97
1,448.76
1,173.27
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
3,043.59
2,686.40
2,063.85
1,988.16
1,981.97
1,448.76
1,173.27
Raw Material Cost
1,879.74
1,581.55
1,120.26
1,013.37
968.45
746.08
643.98
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
32.95
26.72
28.96
24.31
27.72
25.06
17.65
Selling and Distribution Expenses
605.73
578.83
475.25
517.27
515.50
429.66
331.50
Other Expenses
13.76
12.86
8.85
7.96
7.11
5.77
4.07
Total Expenditure (Excl Depreciation)
2,656.04
2,315.71
1,712.93
1,634.59
1,582.78
1,258.52
1,033.82
Operating Profit (PBDIT) excl Other Income
387.5
370.7
350.90000000000003
353.6
399.20000000000005
190.2
139.4
Other Income
40.28
146.81
36.39
47.50
22.71
40.38
45.67
Operating Profit (PBDIT)
613.55
664.26
499.86
487.97
518.46
322.42
277.96
Interest
32.95
26.72
28.96
24.31
27.72
25.06
17.65
Exceptional Items
-14.43
56.22
54.12
107.38
115.67
56.43
-0.53
Gross Profit (PBDT)
1,163.85
1,104.85
943.59
974.79
1,013.52
702.68
529.28
Depreciation
201.67
143.93
112.03
87.74
96.63
92.49
92.84
Profit Before Tax
364.49
549.83
412.98
483.30
509.78
261.31
166.94
Tax
38.46
56.18
40.04
54.20
71.43
36.12
20.90
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
300.72
453.59
346.70
412.78
398.20
194.36
118.98
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
300.72
453.59
346.70
412.78
398.20
194.36
118.98
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
29.11
61.41
27.07
20.81
41.29
29.44
22.07
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
329.83
515.00
373.77
433.59
439.49
223.80
141.04
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
4,469.99
4,565.62
4,221.51
4,032.66
2,455.57
2,121.94
2,076.67
Earnings per share (EPS)
0.65
0.97
0.74
0.88
0.99
0.49
0.29
Diluted Earnings per share
0.65
0.97
0.74
0.88
0.99
0.49
0.29
Operating Profit Margin (Excl OI)
12.21%
13.9%
17.03%
17.74%
20.14%
13.08%
11.89%
Gross Profit Margin
18.6%
25.83%
25.44%
28.72%
30.6%
24.42%
22.14%
PAT Margin
9.88%
16.88%
16.8%
20.76%
20.09%
13.42%
10.14%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2024 is 13.30% vs 30.16% in Dec 2023

stock-summary

Consolidate Net Profit

YoY Growth in year ended Dec 2024 is -35.96% vs 37.77% in Dec 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2024 is 10.80% vs 11.63% in Dec 2023

stock-summary

Interest

YoY Growth in year ended Dec 2024 is 23.60% vs -7.93% in Dec 2023

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Dec 2024 has fallen from Dec 2023

Compare Annual Results Of Tianjin Ringpu Bio-technology Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
3,043.59
0
3,043.59
Other Operating Income
0.00
0.00
0.00
Total Operating income
3,043.59
0
3,043.59
Raw Material Cost
1,879.74
0
1,879.74
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
32.95
0
32.95
Selling and Distribution Expenses
605.73
0
605.73
Other Expenses
13.76
0.00
13.76
Total Expenditure (Excl Depreciation)
2,656.04
0
2,656.04
Operating Profit (PBDIT) excl Other Income
387.54
0.00
387.54
Other Income
40.28
0
40.28
Operating Profit (PBDIT)
613.55
0
613.55
Interest
32.95
0
32.95
Exceptional Items
-14.43
0
-14.43
Gross Profit (PBDT)
1,163.85
0
1,163.85
Depreciation
201.67
0
201.67
Profit Before Tax
364.49
0
364.49
Tax
38.46
0
38.46
Provisions and contingencies
0
0
0.00
Profit After Tax
300.72
0
300.72
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
300.72
0
300.72
Share in Profit of Associates
0
0
0.00
Minority Interest
29.11
0
29.11
Other related items
0.00
0.00
0.00
Consolidated Net Profit
329.83
0
329.83
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
4,469.99
0
4,469.99
Earnings per share (EPS)
0.65
0
0.65
Diluted Earnings per share
0.65
0
0.65
Operating Profit Margin (Excl OI)
12.21%
0%
0.00
12.21%
Gross Profit Margin
18.60%
0%
0.00
18.60%
PAT Margin
9.88%
0%
0.00
9.88%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 304.36 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 13.30% vs 30.16% in Dec 2023

Annual - Consolidate Net Profit
Consolidate Net Profit 32.98 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is -35.96% vs 37.77% in Dec 2023

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 57.33 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 10.80% vs 11.63% in Dec 2023

Annual - Interest
Interest 3.30 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 23.60% vs -7.93% in Dec 2023

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 12.21%
in Dec 2024

Figures in %
stock-summary

YoY Growth in year ended Dec 2024 has fallen from Dec 2023